View in EDS

441O A phase I clinical trial on the intracranial administration of autologous CD1c(BDCA-1)+ /CD141(BDCA-3)+ myeloid dendritic cells (myDC) in combination with ipilimumab (IPI) and nivolumab (NIVO) in patients with recurrent high-grade glioma (rHGG).

Saved in:
Bibliographic Details
Title: 441O A phase I clinical trial on the intracranial administration of autologous CD1c(BDCA-1)+ /CD141(BDCA-3)+ myeloid dendritic cells (myDC) in combination with ipilimumab (IPI) and nivolumab (NIVO) in patients with recurrent high-grade glioma (rHGG).
Authors: Neyns, B.1 (AUTHOR), Dirven, I.1 (AUTHOR), Lescrauwaet, L.2 (AUTHOR), Cammaert, M.1 (AUTHOR), Geens, W.2 (AUTHOR), Geeraerts, X.1 (AUTHOR), Stevens, L.1 (AUTHOR), Brock, S.3 (AUTHOR), Kockx, M.4 (AUTHOR), Everaert, H.5 (AUTHOR), Binst, A-M. Van6 (AUTHOR), Tuyaerts, S.1 (AUTHOR), Duerinck, J.7 (AUTHOR)
Source: Annals of Oncology. 2024 Supplement 2, Vol. 35, pS406-S407. 2p.
Database: Academic Search Ultimate
FullText Text:
  Availability: 0
Header DbId: asn
DbLabel: Academic Search Ultimate
An: 179691909
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: 441O A phase I clinical trial on the intracranial administration of autologous CD1c(BDCA-1)+ /CD141(BDCA-3)+ myeloid dendritic cells (myDC) in combination with ipilimumab (IPI) and nivolumab (NIVO) in patients with recurrent high-grade glioma (rHGG).
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AR" term="%22Neyns%2C+B%2E%22">Neyns, B.</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Dirven%2C+I%2E%22">Dirven, I.</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Lescrauwaet%2C+L%2E%22">Lescrauwaet, L.</searchLink><relatesTo>2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Cammaert%2C+M%2E%22">Cammaert, M.</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Geens%2C+W%2E%22">Geens, W.</searchLink><relatesTo>2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Geeraerts%2C+X%2E%22">Geeraerts, X.</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Stevens%2C+L%2E%22">Stevens, L.</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Brock%2C+S%2E%22">Brock, S.</searchLink><relatesTo>3</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Kockx%2C+M%2E%22">Kockx, M.</searchLink><relatesTo>4</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Everaert%2C+H%2E%22">Everaert, H.</searchLink><relatesTo>5</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Binst%2C+A-M%2E+Van%22">Binst, A-M. Van</searchLink><relatesTo>6</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Tuyaerts%2C+S%2E%22">Tuyaerts, S.</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Duerinck%2C+J%2E%22">Duerinck, J.</searchLink><relatesTo>7</relatesTo> (AUTHOR)
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22Annals+of+Oncology%22">Annals of Oncology</searchLink>. 2024 Supplement 2, Vol. 35, pS406-S407. 2p.
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=asn&AN=179691909
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1016/j.annonc.2024.08.511
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        PageCount: 2
        StartPage: S406
    Titles:
      – TitleFull: 441O A phase I clinical trial on the intracranial administration of autologous CD1c(BDCA-1)+ /CD141(BDCA-3)+ myeloid dendritic cells (myDC) in combination with ipilimumab (IPI) and nivolumab (NIVO) in patients with recurrent high-grade glioma (rHGG).
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Neyns, B.
      – PersonEntity:
          Name:
            NameFull: Dirven, I.
      – PersonEntity:
          Name:
            NameFull: Lescrauwaet, L.
      – PersonEntity:
          Name:
            NameFull: Cammaert, M.
      – PersonEntity:
          Name:
            NameFull: Geens, W.
      – PersonEntity:
          Name:
            NameFull: Geeraerts, X.
      – PersonEntity:
          Name:
            NameFull: Stevens, L.
      – PersonEntity:
          Name:
            NameFull: Brock, S.
      – PersonEntity:
          Name:
            NameFull: Kockx, M.
      – PersonEntity:
          Name:
            NameFull: Everaert, H.
      – PersonEntity:
          Name:
            NameFull: Binst, A-M. Van
      – PersonEntity:
          Name:
            NameFull: Tuyaerts, S.
      – PersonEntity:
          Name:
            NameFull: Duerinck, J.
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 02
              M: 09
              Text: 2024 Supplement 2
              Type: published
              Y: 2024
          Identifiers:
            – Type: issn-print
              Value: 09237534
          Numbering:
            – Type: volume
              Value: 35
          Titles:
            – TitleFull: Annals of Oncology
              Type: main
ResultId 1